The document provided is a bibliography containing 13 references related to Guillain-Barré syndrome. The references discuss topics such as the long term disability and social impacts after Guillain-Barré syndrome, rehabilitation approaches for Guillain-Barré syndrome, pharmacological treatments for Guillain-Barré syndrome besides corticosteroids, intravenous immunoglobulin and plasma exchange, the clinical features, pathogenesis and treatments of Guillain-Barré syndrome, the relationship between Campylobacter gene polymorphism and the clinical presentation of Guillain-Barré syndrome, and Guillain-Barré syndrome in general neurology textbooks.
The document provided is a bibliography containing 13 references related to Guillain-Barré syndrome. The references discuss topics such as the long term disability and social impacts after Guillain-Barré syndrome, rehabilitation approaches for Guillain-Barré syndrome, pharmacological treatments for Guillain-Barré syndrome besides corticosteroids, intravenous immunoglobulin and plasma exchange, the clinical features, pathogenesis and treatments of Guillain-Barré syndrome, the relationship between Campylobacter gene polymorphism and the clinical presentation of Guillain-Barré syndrome, and Guillain-Barré syndrome in general neurology textbooks.
The document provided is a bibliography containing 13 references related to Guillain-Barré syndrome. The references discuss topics such as the long term disability and social impacts after Guillain-Barré syndrome, rehabilitation approaches for Guillain-Barré syndrome, pharmacological treatments for Guillain-Barré syndrome besides corticosteroids, intravenous immunoglobulin and plasma exchange, the clinical features, pathogenesis and treatments of Guillain-Barré syndrome, the relationship between Campylobacter gene polymorphism and the clinical presentation of Guillain-Barré syndrome, and Guillain-Barré syndrome in general neurology textbooks.
The document provided is a bibliography containing 13 references related to Guillain-Barré syndrome. The references discuss topics such as the long term disability and social impacts after Guillain-Barré syndrome, rehabilitation approaches for Guillain-Barré syndrome, pharmacological treatments for Guillain-Barré syndrome besides corticosteroids, intravenous immunoglobulin and plasma exchange, the clinical features, pathogenesis and treatments of Guillain-Barré syndrome, the relationship between Campylobacter gene polymorphism and the clinical presentation of Guillain-Barré syndrome, and Guillain-Barré syndrome in general neurology textbooks.
1. Bersano A, Carpo M, Allaria S, Franciotta D, Citterio A, Nobile-Orazio E.
Long term disability and social status change after Guillain-Barr syndrome. J Neurol. 2006 Feb. 253(2):214-8 2. Mullings KR, Alleva JT, Hudgins TH. Rehabilitation of Guillain-Barr syndrome. Dis Mon. 2010 May. 56(5):288-92 3. Hughes RA, Pritchard J, Hadden RD. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barr syndrome. Cochrane Database Syst Rev. 2013 Feb 28. 2:CD008630 4. Ferri FF. Ferri's Clinical Advisor 2014: 5 Books in 1. Philadelphia, Pa.: Mosby Elsevier; 2014. https://www.clinicalkey.com. Accessed Sept 18, 2016. 5. Yuki N, Hartung HP. Guillain-Barr Syndrome. N Engl J Med. 2012; 366:2294-2304. 6. Van Doorn PA, Ruts L, Jacobs BC. Clinical Features, pathogenesis, and treatment of Guillain-Barr Syndrome. Lancet Neurol. 2008; 7: 939-50. 7. Willison HJ, Jacobs BC, Van Doorn PA. Guillain-Barr syndrome. Lancet. 2016 February, 29; 388: 71727 8. Jacobs BC, Koga M, van Rijs W, Geleijns K, van Doorn PA, Willison HJ, et al. Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barr syndrome. J Neuroimmunol. 2008 Feb. 194(12):181-90 9. Koga M, Takahashi M, Masuda M, Hirata K, Yuki N. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barr syndrome. Neurology. 2005 Nov 8. 65(9):1376-81. 10. Geleijns K, Roos A, Houwing-Duistermaat JJ, van Rijs W, Tio-Gillen AP, Laman JD, et al. Mannose-binding lectin contributes to the severity of Guillain-Barr syndrome. J Immunol. 2006 Sep 15. 177(6):4211-7. 11. Aminoff MJ, Greenberg DA, Simon RP. Clinical neurology. 9th ed. Lange: 2015;307-9 12. Vucic S, Kiernan MC, Cornblath DR. Guillain-Barr syndrome: An update. J Clin Neurosci 2009;16:733741 13. Lidsay KW. Guillain-Barre Syndrome dalam Neurology and Neurosurgery Illustrated. 5th ed. Elsevier: 2011; 422-5.